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Abstract Progesterone at concentrations between 10 WM and
200 WM affected the calcium signaling evoked by ligand
stimulation of G protein-coupled receptors expressed in several
cell lines. At 160 WM progesterone the signaling of all receptors
was completely abolished. The effect of progesterone was fast,
reversible and was not prevented by cycloheximide indicating its
non-genomic nature. Overall, the action of progesterone was
more cell type-specific than receptor-specific. Our results are in
contrast to a recent report [Grazzini, E., Guillon, G., Mouillac,
B. and Zingg, H.H. (1998) Nature 392, 509^512] in which a
direct high-affinity interaction between the oxytocin receptor and
progesterone was suggested.
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1. Introduction
Steroid hormones such as progesterone in£uence cell func-
tions by binding to intracellular receptors which act as tran-
scription factors in regulating protein synthesis. However,
over the years, non-genomic e¡ects of steroid hormones
have become more and more evident (reviewed in [1]). Exam-
ples of progesterone-induced non-genomic e¡ects are the in-
hibition of cholesterol biosynthesis [2], the initiation of meio-
sis in prophase-arrested amphibian oocytes [3] or the
stimulation of the human sperm acrosome reaction [4]. In
human sperm, for instance, progesterone produces a number
of e¡ects which resemble the action of extracellular ligands
such as peptide hormones: a rapid increase of intracellular
calcium concentration, tyrosine phosphorylation of proteins,
e¥ux of chloride, stimulation of activity of phospholipases [4],
activation of protein kinase C [5] and of extracellular signal-
regulated kinases (ERKs) [6]. In order to initiate oocyte ma-
turation or to inhibit cholesterol biosynthesis, progesterone
concentrations in the micromolar range are necessary.
During pregnancy, progesterone maintains uterus quies-
cence, i.e. it reduces the sensitivity of this organ to oxytocin,
a uterotonic neurohypophyseal hormone. However, the
underlying mechanism of this e¡ect is unclear. It has been
proposed that non-genomic progesterone e¡ects contribute
to the maintenance of pregnancy [7,8]. In particular, a direct
high-a⁄nity interaction of progesterone and the oxytocin re-
ceptor has been postulated [8]. Grazzini et al. claimed that
progesterone could act as a negative allosteric modulator of
the oxytocin receptor and thus o¡ered a plausible mechanism
of how progesterone could contribute to uterine quiescence
[8].
To address this in more detail, we investigated in several
cell lines the in£uence of progesterone on the function of the
oxytocin receptor and other G protein-coupled receptors
(GPCRs). Hormones which activate the phosphoinositide cas-
cade lead to a rapid increase of the cytosolic calcium concen-
tration. We show that progesterone is able to markedly a¡ect
the calcium signaling function of GPCRs by a non-genomic
mechanism. Overall, the action of progesterone was more cell
type-speci¢c than receptor-speci¢c. Possible physiological im-
plications are discussed.
2. Materials and methods
2.1. Materials
[Tyrosyl-2,6-3H]oxytocin (NET-858, 48.5 Ci/mmol) was from NEN
Du Pont de Nemours (Bad Homburg, Germany). RU-486 was a gift
from Schering, Berlin, Germany. The ligands oxytocin, bradykinin,
vasopressin, cholecystokinin-8, and the peptide SFLLRNP were
from Bachem (Heidelberg, Germany). All other ligands, steroids,
chemicals and culture media were purchased from Sigma (Deisenho-
fen, Germany).
2.2. Cell cultures and transfections
The following cell lines were used: human embryonic kidney cells
(HEK293) untransfected (HEK293) or stably transfected with the
human oxytocin receptor (HEK-OTR), the human V1 vasopressin
receptor (HEK-V1R) or the human cholecystokininB receptor
(HEK-CCKR), 1321N1, a human astrocytoma cell line, and Chinese
hamster ovary cells (CHO) untransfected (CHO-K1) or stably trans-
fected with the human oxytocin receptor (CHO-OTR). The 1321N1
astrocytoma cell line was a generous gift from Dr. Toews (Nebraska,
USA). HEK293 and CHO-K1 were stably transfected as described [9].
HEK293 and 1321N1 astrocytoma cells were cultured in Dulbecco’s
modi¢ed Eagle’s medium (DMEM) supplemented with 10% and 5%
fetal calf serum, respectively. CHO cells were cultured in DMEM/F-
12 Ham supplemented with 10% fetal calf serum.
2.3. Membrane preparation and receptor binding assays
Membranes of HEK-OTR and CHO-OTR cells were prepared as
described [9] and resuspended in binding bu¡er (20 mM HEPES, pH
7.4 and 5 mM MgCl2). Membranes (150 Wg) were incubated with
10 nM [3H]oxytocin in a total volume of 100 Wl binding bu¡er for
30 min at 30‡C. The binding reaction was stopped by addition of ice-
cold binding bu¡er and bound ligand was separated from free ligand
by rapid ¢ltration over Whatman GF/C ¢lters. Non-speci¢c binding
was determined in the presence of a 500-fold excess of unlabeled oxy-
tocin.
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2.4. Measurement of intracellular free calcium ion concentration
[Ca2]i
Cells were loaded with 1.5 WM fura-2/AM for 30 min at 37‡C. They
were detached using PBS/0.5 mM EDTA and centrifuged at 100Ug
for 10 min. The pellet was washed and resuspended in calcium bu¡er
(10 mM HEPES, pH 7.4, 140 mM NaCl, 5 mM KCl, 0.5 mM MgCl2,
1.5 mM CaCl2, 10 mM glucose) at a concentration of 2U106 cells/ml.
Aliquots of the suspension (1U106 cells) were transferred into a ther-
mostated (37‡C) cuvette containing 2.5 ml calcium bu¡er. Ligands
were applied to the cells and the changes of the [Ca2]i were moni-
tored spectro£uorimetrically. The [Ca2]i was calculated by using the
ratio 340/380 nm (emission at 510 nm).
2.5. Treatment of cells and membranes with steroids
All steroids were dissolved in ethanol. The steroids were added to
fura-2/AM-loaded cells in calcium bu¡er (¢nal concentration of etha-
nol 6 0.8% (v/v)). The cells were incubated for 10 min at 37‡C and
subsequently for 10 min at 25‡C prior to their use for calcium meas-
urements. In a further series of experiments, the steroids were added
to membranes of HEK-OTR or CHO-OTR cells in binding bu¡er
(¢nal concentration of ethanol 6 1% (v/v)). Membranes were ¢rst
incubated for 10 min at 30‡C and were subsequently used for the
ligand binding assays.
2.6. Measurement of steady-state anisotropy
Steroid-treated cells in calcium bu¡er (1U106 cells/ml) were soni-
cated on ice using a Branson soni¢er. The cell lysate was labeled with
2 WM 1,6-diphenyl-1,3,5-hexatriene (DPH) for 60 min at 30‡C to
obtain maximum £uorescence intensity. The polarization measure-
ments were performed as described [9].
3. Results
3.1. Determination of receptor subtypes
Ligand-induced increase of the intracellular free calcium ion
concentration was measured in various cell lines using the
following ligands at the indicated concentrations: acetylcho-
line (100 WM), bradykinin (1 WM), histamine (100 WM), oxy-
tocin (100 nM), (Arg8)-vasopressin (AVP) (100 nM), cholecys-
tokinin (CCK-8) (100 nM), and the peptide SFLLRNP (1
WM). The peptide SFLLRNP is an agonist of the thrombin
receptor which is endogenously expressed in CHO cell lines.
In the following cell lines an increase of [Ca2]i was elicited by
the indicated ligands: HEK293 (acetylcholine, bradykinin);
HEK-V1R (acetylcholine, bradykinin, AVP); HEK-CCKR
(acetylcholine, bradykinin, CCK-8); HEK-OTR (acetylcho-
line, bradykinin, oxytocin); CHO-K1 (CCK-8, SFLLRNP);
CHO-OTR (CCK-8, SFLLRNP, oxytocin); 1321N1 (acetyl-
choline, bradykinin, histamine). HEK293 and 1321N1 cells
endogenously express the M3 subtype of the muscarinic ace-
tylcholine receptor and the B2 subtype of the bradykinin re-
ceptor, 1321N1 cells express the H1 subtype of the histamine
receptor as indicated by their pharmacological pro¢le (data
not shown).
3.2. E¡ect of progesterone on calcium signaling of di¡erent
GPCRs in various cell lines
Pretreatment of 1321N1 cells or di¡erent HEK293 cell lines
with progesterone (10^200 WM) attenuated the agonist-stimu-
lated signaling of all receptors investigated (Fig. 1A,B). At
160 WM progesterone, the signaling of all receptors was com-
pletely abolished. The IC50 values (WM progesterone) were as
follows: (1) 1321N1 cells: acetylcholine receptor, 125 þ 2.5;
bradykinin receptor, 103 þ 8.3; histamine receptor, 117 þ 3.2;
(2) HEK293 cell lines: acetylcholine receptor, 73 þ 6.7; brady-
kinin receptor, 53 þ 11.3; oxytocin receptor, 56 þ 6.1; vaso-
pressin receptor, 77 þ 6.2; cholecystokinin receptor, 86 þ 4.3.
Acetylcholine receptors in the di¡erent HEK293 cell lines re-
vealed no signi¢cant di¡erences with respect to the IC50 values
of progesterone. This allowed us to directly compare various
GPCRs in the di¡erent HEK293 cell lines. Overall, the di¡er-
ent receptors revealed IC50 values of progesterone which were
lower in HEK293 cells as compared with 1321N1 cells. This
suggests a more cell type-speci¢c action of progesterone. This
assumption was con¢rmed in experiments with CHO-OTR
cells. Surprisingly, the highest ligand-induced calcium signal
was obtained when the cells were pretreated with about 50
WM progesterone (Fig. 1C). At progesterone concentrations
higher than 60 WM, the calcium signals were dose-dependently
diminished. As observed in HEK293 and 1321N1 cells, the
Fig. 1. E¡ects of increasing concentrations of progesterone on the
ligand-induced calcium signaling of G protein-coupled receptors in
(A) 1321N1 astrocytoma cells, (B) HEK293 cell lines and (C) CHO-
OTR cells. Data are expressed as percent of control, i.e. ‘ethanol-
treated’ cells. The basal [Ca2]i was between 50 and 100 nM (de-
pending on the cell line). Following ligand application the [Ca2]i of
control cells increased 2^5-fold over basal value (depending on both
ligand and cell line).
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calcium responses were completely abolished when the cells
were pretreated with 160 WM progesterone. Side e¡ects of the
transfection leading to this conspicuous behavior of CHO
cells could be excluded, since progesterone had the same e¡ect
on the peptide SFLLRNP-induced calcium signaling in trans-
fected (CHO-OTR) versus untransfected CHO-K1 cells (not
shown).
3.3. Kinetics of the progesterone action
The calcium response of acetylcholine-stimulated 1321N1
cells was measured at di¡erent times after addition of 160
WM progesterone to the cells (Fig. 2A). After 3 min, the cal-
cium response was reduced to 30% of control (i.e. ethanol-
treated cells). Incubation of the cells with progesterone for
more than 11 min prevented the calcium response completely.
Next, we analyzed whether this progesterone e¡ect was rever-
sible. After removal of progesterone by centrifugation and a
washing step with progesterone-free calcium bu¡er, the calci-
um signals increased to a level of 50% of control after 13 min.
Finally, the 100% control level was regained after about 60
min (Fig. 2B). The e¡ect of progesterone was not prevented
when the cells had been pretreated with cycloheximide (160
WM) for at least 4 h at 37‡C (not shown). Taken together, the
action of progesterone is fast and reversible and not a¡ected
by an inhibitor of protein synthesis indicating a non-genomic
pathway.
3.4. E¡ect of progesterone on the ligand receptor interaction
In further experiments we analyzed whether the observed
e¡ects of progesterone on the calcium signaling of GPCRs
were due to an in£uence on the ligand^receptor interaction.
As an example, we treated membranes of both CHO-OTR
and HEK-OTR cells with increasing amounts of progesterone
as well as the progesterone metabolite 5L-pregnane-3,20-dione
and measured the speci¢c binding of [3H]oxytocin (Fig. 3).
This progesterone derivative was used because Grazzini et
al. previously reported an inhibition of [3H]oxytocin binding
to the human oxytocin receptor in membranes of CHO cells
by 5L-pregnane-3,20-dione (Ki = 32 þ 5 nM) but not by pro-
gesterone (up to 10 WM) [8]. In contrast to the results of
Grazzini et al., we needed approximately 6000-fold higher
concentrations of 5L-pregnane-3,20-dione to reduce the spe-
ci¢c binding of [3H]oxytocin. The required concentrations for
half-maximal suppression were as follows: (1) progesterone:
HEK-OTR membranes, 417 þ 4.2 WM; CHO-OTR mem-
branes, 138 þ 6.9 WM; (2) 5L-pregnane-3,20-dione: HEK-
OTR membranes, 244 þ 28.0 WM; CHO-OTR membranes,
180 þ 12.6 WM. The corresponding slope factors were found
to be high for all curves (see legend to Fig. 3). This was most
obvious for membranes of HEK-OTR cells treated with pro-
gesterone. This threshold-like e¡ect may re£ect alterations in
the physical properties of the membrane bilayer such as £uid-
ity changes which occur at such high progesterone concentra-
tions (see Section 3.5).
3.5. In£uence of progestins on the £uidity of membranes
Next, we investigated whether the progestin concentrations
used in our experiments had an in£uence on the membrane
£uidity. For this purpose, we measured the anisotropy of the
£uorescent dye DPH in membranes of HEK-OTR cells
treated with progesterone or 5L-pregnane-3,20-dione. At pro-
gestin concentrations of 60 WM, no changes of the anisotropy
values were observed as compared with control, i.e. ‘ethanol-
Fig. 2. Kinetics of progesterone action. The calcium response of
1321N1 astrocytoma cells on 100 WM acetylcholine was measured
(A) at di¡erent times after addition of 160 WM progesterone to the
cells and (B) after removal of progesterone. Data are expressed as
percent of control, i.e. ‘ethanol-treated’ cells.
Fig. 3. E¡ects of progestins on the ligand binding activity of the hu-
man oxytocin receptor. Membranes of HEK-OTR/CHO-OTR cells
were incubated with increasing concentrations of progesterone (a/E)
or the progesterone metabolite 5L-pregnane-3,20-dione (b/F) for 10
min at 30‡C. Subsequently, the membranes (150 Wg each) were used
for ligand binding assay as described. Data are expressed as percent
of control, i.e. ‘ethanol-treated’ membranes (100% is equal to 4130
dpm and 2090 dpm of speci¢cally bound [3H]oxytocin for mem-
branes of CHO-OTR and HEK-OTR cells, respectively). The data
were ¢tted according to the equation: y = 100/(1+10logb3logxUa),
where b is the IC50 value and a is the slope factor. The slope factor
values were as follows: 339.2 (a), 33.6 (E), 32.9 (b) and 33.6
(F). The IC50 values are shown in Section 3.4.
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treated’ cells (r = 0.1813 þ 0.00327). In contrast, when the
membranes were treated with 450 WM progestin, a concentra-
tion at which an interference with the ligand^receptor inter-
action has been shown (see Section 3.4), the anisotropy values
were slightly reduced (progesterone, r = 0.1719 þ 0.00064;
5L-pregnane-3,20-dione, r = 0.1752 þ 0.00983).
3.6. Structure^activity analysis of several steroids
To demonstrate the speci¢city of the progesterone action,
various steroids were tested for their ability to diminish the
ligand-induced calcium signaling. For this purpose, HEK-
OTR cells were treated with di¡erent steroids (each at
60 WM). The steroids showed the following order of potency
(oxytocin-induced calcium response in % of control, i.e. etha-
nol-treated cells, Fig. 4): progesterone (29 þ 5%) = 5L-preg-
nane-3,20-dione (26 þ 5%)Dpregnenolone (75 þ 4%)vL-estra-
diol (81 þ 4%)vdehydroepiandrosterone (DHEA) (85 þ 6%).
Cholesterol slightly increased the calcium response on
100 nM oxytocin whereas its derivative lanosterol showed
no e¡ect. RU-486, a synthetic antagonist of the classical pro-
gesterone receptor, was less e¡ective than progesterone. Treat-
ment of cells with 70 WM or 160 WM RU-486 reduced the
calcium response to 82 þ 5.9% and 64 þ 2.6% of control levels,
respectively. In addition, RU-486 did not act as an antagonist
of progesterone (Fig. 4).
4. Discussion
In this study, we demonstrate that progesterone can specif-
ically a¡ect the calcium signaling evoked by ligand stimula-
tion of GPCRs. Several mechanisms that could account for
the non-genomic e¡ects of progesterone are not supported by
our ¢ndings. (1) Progesterone could directly interact with the
receptor thereby disturbing ligand binding. For example, pro-
gesterone was reported to interact with an extracellular site of
the major brain nicotinic acetylcholine receptor, thus leading
to inhibition of acetylcholine-evoked currents (IC50W10 WM)
[10]. In the case of GPCRs which we have studied, several-
fold higher progestin concentrations were needed to interfere
with the ligand binding than to a¡ect the ligand-induced cal-
cium signaling. Our results are in contrast to those of Grazzini
et al. who suggested a direct high-a⁄nity interaction between
5L-pregnane-3,20-dione and the human oxytocin receptor [8].
These authors measured an inhibition of [3H]oxytocin binding
to the human oxytocin receptor in CHO membranes by 5L-
pregnane-3,20-dione with Ki = 32 þ 5 nM whereas we observed
e¡ects on ligand binding with 5L-pregnane-3,20-dione only at
concentrations in the high micromolar range. (2) Progesterone
may also in£uence receptor properties by changing the mem-
brane £uidity. In fact, the membrane £uidity was slightly in-
creased in membranes at 450 WM progesterone. This change in
£uidity may contribute to the reduction of the ligand binding
activity of the human oxytocin receptor in membranes of
HEK-OTR or CHO-OTR cells. However, we observed no
changes in the membrane £uidity at progesterone concentra-
tions that a¡ected the ligand-induced calcium signaling of
GPCRs. (3) A well-known progesterone binding protein is
the multidrug resistance P-glycoprotein [11] which acts as an
energy-dependent drug e¥ux pump that reduces drug cytotox-
icity when overexpressed (reviewed in [12]). Besides their role
in detoxi¢cation, MDR P-glycoproteins are involved in intra-
cellular sterol transport [13]. Progesterone inhibits the activity
of P-glycoprotein and in turn blocks the cholesterol biosyn-
thesis thus leading to the accumulation of cholesterol precur-
sors such as lanosterol [2]. We show here that lanosterol itself
did not a¡ect the calcium signaling of the oxytocin receptor.
Steroids like DHEA and pregnenolone are strong inhibitors of
MDR P-glycoprotein mediated drug e¥ux [13] but they had
little e¡ect on calcium signaling of GPCRs in this study. Thus,
an action of progesterone via this P-glycoprotein seems to be
unlikely although an e¡ect of progesterone on other related
transporters cannot be excluded.
Our ¢ndings might be explained by the following observa-
tions. (1) Progesterone at concentrations used in our study has
been reported to cause a rapid decline in the cholesterol level
of caveolae, i.e. sphingomyelin/cholesterol-rich subdomains of
the plasma membrane [14]. The signaling of the oxytocin re-
ceptor [9] and many other GPCRs (Burger et al., unpublished)
depends on cholesterol. As many GPCRs and other molecules
of the signaling cascade are enriched in caveolae [15], alter-
ations in the cholesterol content of these microdomains by
progesterone could lead to changes in the calcium signaling
of GPCRs. (2) Progesterone could act on later steps of the
signaling cascade. It may regulate the calcium channels of the
plasma membrane or the membrane of the endoplasmic retic-
ulum. This has been reported for intestinal smooth muscle
cells where progesterone and 5L-pregnane-3,20-dione de-
creased voltage-gated calcium currents [16].
Conclusively, the progesterone doses which are required to
a¡ect the signaling function of receptors are higher than the
progesterone levels found in plasma or in non-steroidogenic
tissues such as the human myometrium [17]. Thus, our data
do not support a non-genomic progesterone action within
non-steroidogenic tissues. On the other hand, exceedingly
high progesterone concentrations have been measured in spe-
cialized steroidogenic tissues, such as the placenta and corpus
luteum. Near term, the human placenta secretes upward of
300 mg of progesterone daily. The progesterone content of
this organ was shown to be 7 Wg/g wet tissue [18]. In human
corpus luteum, progesterone concentrations were cycle-de-
pendent and reached peak levels of about 25 Wg/g tissue
Fig. 4. Structure^activity analysis of steroids on receptor-mediated
calcium signaling. HEK-OTR cells were incubated with di¡erent ste-
roids (60 WM each, unless indicated otherwise) and the calcium re-
sponse on 100 nM oxytocin was measured. Data are expressed as
percent of control, i.e. ‘ethanol-treated’ cells.
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shortly after ovulation and in the early luteal phase [19].
Rough calculations show that all these values are within the
range of the progesterone concentrations which were e¡ective
in our study. Thus, in steroidogenic cells as well as in their
environment, progesterone might in£uence the e¡ect of the
ligands via non-genomic modulation of the ligand-induced
calcium responses. In these tissues, the oxytocin system has
also been discussed to play an important physiological role.
For example, in the primate ovary, oxytocin is reported to
function as a paracrine mediator in the luteinization process
[20]. Moreover, during the course of human parturition, an
enhanced expression of oxytocin receptors in chorio-decidual
tissues was reported to occur [21]. Further studies are required
to analyze the level of non-genomic action relative to the
classical genomic e¡ects of progesterone in reproductive tis-
sues.
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